Usefulness of Fetuin-A to Predict Risk for Cardiovascular Disease Among Patients With Obstructive Sleep Apnea

American Journal of Cardiology

Volumn 116, Issue 2, 2015, Pages 219-224

  Liu, Alice ^a   Lamendola, Cindy ^a   Ariel, Danit ^a   Abbasi, Fahim ^a   Kim, Sun H ^a   Cardell, James ^a   Tomasso, Vanessa ^a   Xu, Shiming ^a   Patel, Shailja ^a   Mojaddidi, Hafasa ^a   Grove, Kaylene ^a   Kushida, Clete A ^b   Reaven, Gerald M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; FETUIN A; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LIPOPROTEIN; LIPOPROTEIN A; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PATHOGENESIS; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; STATISTICAL SIGNIFICANCE; STEADY STATE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; INCIDENCE; METABOLISM; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

ADULT; AGED; ALPHA-2-HS-GLYCOPROTEIN; BIOMARKERS; CALIFORNIA; CARDIOVASCULAR DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84931566184     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.04.014     Document Type: Article

References (29)

1. P. Kohli, J.S. Balachandran, and A. Malhotra Obstructive sleep apnea and the risk for cardiovascular disease Curr Atheroscler Rep 13 2011 138 146
2. C. Schafer, A. Heiss, A. Schwarz, R. Westenfeld, M. Ketteler, J. Floege, W. Muller-Esterl, T. Schinke, and W. Jahnen-Dechent The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification J Clin Invest 112 2003 357 366
3. J.H. Ix, E. Barrett-Connor, C.L. Wassel, K. Cummins, J. Bergstrom, L.B. Daniels, and G.A. Laughlin The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo Study J Am Coll Cardiol 58 2011 2372 2379
4. G.A. Laughlin, K.M. Cummins, C.L. Wassel, L.B. Daniels, and J.H. Ix The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: the Rancho Bernardo study J Am Coll Cardiol 59 2012 1688 1696
5. Q. Sun, M.C. Jimenez, M.K. Townsend, E.B. Rimm, J.E. Manson, C.M. Albert, and K.M. Rexrode Plasma levels of fetuin-A and risk of coronary heart disease in US women: the Nurses' Health Study J Am Heart Assoc 3 2014 e000939
6. C. Weikert, N. Stefan, M.B. Schulze, T. Pischon, K. Berger, H.G. Joost, H.U. Haring, H. Boeing, and A. Fritsche Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke Circulation 118 2008 2555 2562
7. J.H. Ix, M.G. Shlipak, V.M. Brandenburg, S. Ali, M. Ketteler, and M.A. Whooley Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study Circulation 113 2006 1760 1767
8. C.H. Jung, B.Y. Kim, C.H. Kim, S.K. Kang, S.H. Jung, and J.O. Mok Associations of serum fetuin-A levels with insulin resistance and vascular complications in patients with type 2 diabetes Diab Vasc Dis Res 10 2013 459 467
9. K. Mori, M. Emoto, H. Yokoyama, T. Araki, M. Teramura, H. Koyama, T. Shoji, M. Inaba, and Y. Nishizawa Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects Diabetes Care 29 2006 468
10. A. Song, M. Xu, Y. Bi, Y. Xu, Y. Huang, M. Li, T. Wang, Y. Wu, Y. Liu, X. Li, Y. Chen, W. Wang, and G. Ning Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults PLoS One 6 2011 e19228
11. N. Stefan, Q. Sun, A. Fritsche, J. Machann, F. Schick, F. Gerst, C. Jeppesen, H.G. Joost, F.B. Hu, H. Boeing, S. Ullrich, H.U. Haring, and M.B. Schulze Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies PLoS One 9 2014 e92238
12. J.H. Ix, M.L. Biggs, K.J. Mukamal, J.R. Kizer, S.J. Zieman, D.S. Siscovick, D. Mozzaffarian, M.K. Jensen, L. Nelson, N. Ruderman, and L. Djousse Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study Circulation 125 2012 2316 2322
13. E. Tasali, B. Mokhlesi, and E. Van Cauter Obstructive sleep apnea and type 2 diabetes: interacting epidemics Chest 133 2008 496 506
14. R.B. Berry, R. Budhiraja, D.J. Gottlieb, D. Gozal, C. Iber, V.K. Kapur, C.L. Marcus, R. Mehra, S. Parthasarathy, S.F. Quan, S. Redline, K.P. Strohl, S.L. Davidson Ward, and M.M. Tangredi Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine J Clin Sleep Med 8 2012 597 619
15. J.W. Knowles, T.L. Assimes, P.S. Tsao, A. Natali, A. Mari, T. Quertermous, G.M. Reaven, and F. Abbasi Measurement of insulin-mediated glucose uptake: direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp Metabolism 62 2013 548 553
16. M.S. Greenfield, L. Doberne, F. Kraemer, T. Tobey, and G. Reaven Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp Diabetes 30 1981 387 392
17. A. Liu, J. Cardell, D. Ariel, C. Lamendola, F. Abbasi, S.H. Kim, T.H. Holmes, V. Tomasso, H. Mojaddidi, K. Grove, C.A. Kushida, and G.M. Reaven Abnormalities of lipoprotein concentrations in obstructive sleep apnea are related to insulin resistance Sleep 38 2015 793 799
18. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, and S.C. Smith Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 2009 1640 1645
19. B.M. Kaess, D.M. Enserro, D.D. McManus, V. Xanthakis, M.H. Chen, L.M. Sullivan, C. Ingram, C.J. O'Donnell, J.F. Keaney, R.S. Vasan, and N.L. Glazer Cardiometabolic correlates and heritability of fetuin-A, retinol-binding protein 4, and fatty-acid binding protein 4 in the Framingham Heart Study J Clin Endocrinol Metab 97 2012 E1943 E1947
20. A. Obuchi, H. Adachi, M. Enomoto, A. Fukami, E. Kumagai, S. Nakamura, A. Yoshimura, Y. Nohara, E. Nakao, Y. Umeki, Y. Fukumoto, and T. Imaizumi High plasma fetuin-A levels are associated with metabolic syndrome among males but not females in a Japanese general population Diabetes Res Clin Pract 106 2014 128 135
21. Y. Xu, M. Xu, Y. Bi, A. Song, Y. Huang, Y. Liu, Y. Wu, Y. Chen, W. Wang, X. Li, and G. Ning Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese Atherosclerosis 216 2011 180 186
22. M.J. Chapman, H.N. Ginsberg, P. Amarenco, F. Andreotti, J. Boren, A.L. Catapano, O.S. Descamps, E. Fisher, P.T. Kovanen, J.A. Kuivenhoven, P. Lesnik, L. Masana, B.G. Nordestgaard, K.K. Ray, Z. Reiner, M.R. Taskinen, L. Tokgozoglu, A. Tybjaerg-Hansen, and G.F. Watts Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management Eur Heart J 32 2011 1345 1361
23. L. Kumbla, S. Bhadra, and M.T. Subbiah Multifunctional role for fetuin (fetal protein) in lipid transport FASEB J 5 1991 2971 2975
24. P. Auberger, L. Falquerho, J.O. Contreres, G. Pages, G. Le Cam, B. Rossi, and A. Le Cam Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity Cell 58 1989 631 640
25. K. Mori, M. Emoto, T. Araki, H. Yokoyama, M. Teramura, E. Lee, K. Motoyama, H. Koyama, T. Shoji, M. Inaba, and Y. Nishizawa Association of serum fetuin-A with carotid arterial stiffness Clin Endocrinol (Oxf) 66 2007 246 250
26. A. Akyuz, M. Oran, S. Alpsoy, L.C. Mutlu, D.C. Akkoyun, S. Guzel, and R. Alp Association between serum fetuin-a levels, carotid artery stiffness, and Intima-Media thickness in patients with Normotensive obstructive sleep apnea syndrome Angiology 65 2013 607 613
27. E.R. Smith, and S.G. Holt Important differences in measurement of fetuin-A Ann Intern Med 153 2010 419 author reply 419-420
28. N. Stefan, and H.U. Haring Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans Nat Med 19 2013 394 395
29. A. Barcelo, J. Pierola, C. Esquinas, M. de la Pena, M. Arque, M.S. la Torre, A. Alonso-Fernandez, and F. Barbe Reduced plasma fetuin-A levels in patients with obstructive sleep apnoea Eur Respir J 40 2012 1046 1048